В известной мере, - Эпонина встала. - Элли, где. Твой отец уже задает вопросы. - Минуточку, - они услышали голос Элли.
The biologic cervical cancer metastatic sites of squamous cervical carcinoma after neoadjuvant therapy NAT according to immunohistochemical expression of E-cadherin and CD44v6 Mihaela Madalina Gavrilescu, Raluca Balan, Viorel Scripcariu, Dan Ferariu, Ludmila Lozneanu, Diana Popovici, Cornelia Amalinei Abstract The efficiency of neoadjuvant therapy in cervical carcinoma has been well demonstrated, although the cellular mechanisms of different response to this treatment have not been thoroughly investigated.
The aim of our study was to assess the correlations between the alterations in E-cadherin and CD44v6 immunoexpression in cervical carcinoma, as a tool of evaluation the response to neoadjuvant therapy and its prognostic significance.
Facing such a scenario, the only solution is following a sequence of investigations and therapy steps towards a correct and complete diagnosis if possible. We review the current literature data and present a personal case. There are many controversies regarding the primitive metastatic neck lymph nodes related to cervical cancer metastatic sites optimum management, balanced with benefit for the patient.
The intensity of CD44v6 immunoexpression was higher in cervical cancer metastatic sites aggressive tumors and E-cadherin immunoexpression was approximately constant among the cases with neoadjuvant therapy. Our results demonstrate that the evaluation of CD44v6 immunoexpression in cervical carcinomas is useful for the assessment of tumor response to neoadjuvant therapy and of tumor aggressiveness.
Глядя на происходящее, нетрудно видеть, как широко разбросаны эти огоньки даже через десять миллионов лет эволюции.
The high level of E-cadherin immunoexpression in tumors with neoadjuvant therapy reflects its involvement in the prevention of HPV oncoproteins action, with benefits on cervical cancer metastatic sites outcome. A cervical cancer metastatic sites group of patients and a panel of antibodies, including CD4 and COX2, could provide a better characterization of the tumor response to neoadjuvant therapy, with a positive prognosis impact.
Int J Cancer ; Rom J Morphol Embryol ; CD44 isoform 6 CD44v6 is a prognostic indicator of the response to neoadjuvant chemotherapy in cervical carcinoma.
Gynecol Oncol ; 80 1 CD 44 exon v6 as a predictor of lymphatic cervical cancer metastatic sites in cervical carcinoma--an immunocytochemical study of 94 cases. Arch Gynecol Obstet ; 3 Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancer. Int J Cancer ; 69 3 CD44 is an independent prognostic factor in early-stage cervical cancer.
Int J Cancer ; 74 2 E-cadherin and alpha-catenin expression during tumor progression of sunt praf parazitii carcinoma. Gynecol Oncol ; Braz Dent J ; 20 1 Cervical cancer metastatic sites Res ; Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma.
J Pathol ; 2 Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol ; Hirohashi S, Kanai Y.
Cell adhesion system and human cancer morphogenesis. Cancer Sci ; HPV16 E7 oncogene expression in normal human epithelial cells causes molecular changes indicative of an epithelial to mesenchymal transition. Virology ; 1 Tumor biomarkers in cervical cancer: focus on Ki proliferation factor and E-cadherin expression.
Significance of E-cadherin, beta-catenin, and vimentin expression as postoperative prognosis indicators in cervical squamous cell carcinoma. Hum Pathol ;
- Cervical Cancer Awareness Week - Canadian Cancer Society
- Papilloma in males
Те, кто знает по себе, что такое роды, и те, кто не знает этого".